We’re excited to announce the launch of Drug Discovery Innovators & Investors (DDII) – a new event series from Drug Discovery World.

The three-part global event series focuses on technology, innovation, and investment in early-stage drug discovery. Bringing together senior executives, R&D leaders, lab managers, and decision-makers from pharma and biotech companies, the series provides a unique platform for industry suppliers to connect with key buyers and influencers. Attendees also include leaders from academia, start-ups, spin-outs, and the investment community, creating a highly collaborative environment for partnership, innovation, and business growth.

Upcoming Events

Digital Forum – 30 September 2026 (Online)
Innovation to Investment: Driving Growth in Early-stage Drug Discovery
Lead Sponsor: Curia
Join us online for a half day of sessions exploring collaboration, lab effectiveness, emerging therapies and modalities, and the capital flows driving early-stage innovation.
Registration now open.

London, UK – 4 November 2026 (In Person)
Technology, Scale, and Capital: Advancing UK Drug Discovery and Development 
Join us for the full-day, in-person conference at etc.venues Monument, London. Through expert-led discussions and networking, attendees will gain insights into the impact of AI and emerging technologies, access to early-stage capital, regulatory developments, and the strategies and partnerships needed to accelerate the path from discovery to patient impact.
Registration now open.

Basel, Switzerland – March 2027 (In Person)
Scaling European Drug Discovery Through Technology, Investment & Collaboration
DDII heads to Basel for the final event in the series, bringing the conversation to the heart of Europe’s life sciences ecosystem.
Save the date – more details coming soon.

We look forward to welcoming you to one or all of our events.

Explore the event series and register here.